Using a new PCR system to understand pancreatic cancer better
CFX Opus 96 Real-Time PCR System for precision genotyping and phenotyping
This study is looking at how certain proteins affect the growth and spread of pancreatic cancer, with the hope of finding new ways to improve treatment for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11099357 on NIH RePORTER |
What this research studies
This research focuses on pancreatic cancer, one of the deadliest cancers, by investigating the role of specific proteins in cancer development. The team will utilize a state-of-the-art PCR system to analyze genetic and phenotypic variations in cancer cells, particularly looking at how certain proteins influence tumor growth and spread. By understanding these mechanisms, the research aims to uncover new targets for therapy that could improve treatment outcomes for patients. The approach involves detailed molecular analysis and manipulation of cancer cell signaling pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer who are seeking new treatment options.
Not a fit: Patients with other types of cancer or those without a pancreatic cancer diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies that significantly improve survival rates for pancreatic cancer patients.
How similar studies have performed: Previous research has shown promise in targeting similar signaling pathways in other cancers, suggesting potential for success in this novel approach.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Yan, Ying — University of Nebraska Medical Center
- Study coordinator: Yan, Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.